Taylor Nayman

Taylor Nayman is a Clinical Assistant Professor in the Department of Ophthalmology at the University of Montreal's Faculty of Medicine. She practices glaucoma surgery at Maisonneuve-Rosemont Hospital and teaches medical students, ophthalmology residents, and glaucoma fellows. Her clinical expertise focuses on surgical glaucoma management and ocular biomechanics research.

Her educational background includes:

• Doctor of Medicine, McGill University (2017)
• Residency in Ophthalmology, University of Montreal (2022)
• Fellowship in Glaucoma Surgery, Mayo Clinic (2023)

Dr. Nayman's research spans glaucoma diagnostics, ocular biomechanics, aqueous humor dynamics, and AI applications in ophthalmology. She has published extensively on Boston keratoprosthesis outcomes, glaucoma screening in underserved populations, and surgical complications. Her work integrates clinical practice with innovative research to advance glaucoma therapeutics globally.

Recent publications reveal a strategic shift toward interdisciplinary collaboration, combining ophthalmology with artificial intelligence for diagnostic enhancement and data-driven surgical outcomes analysis. Key themes include AI performance validation in complex cases, biomechanical modeling of ocular structures, and global health applications for glaucoma detection.

Her scientific distinctions include:

• Top Poster, American Glaucoma Society Annual Meeting (2024)
• Robert W. Hollenhorst Research Award, Mayo Clinic (2023)
• Mayo Clinic CCATS Research Grant (2022)
• FROUM Research Grant, University of Montreal (2018)
• Dr. Mark Cohen Ophthalmology Award, McGill University (2017)

Dr. Nayman actively mentors trainees and leads the UdeM Haiti Glaucoma initiative, organizing annual screening clinics in Montreal's Haitian community. Her research has secured competitive funding including Mayo Clinic and FROUM grants supporting projects on ocular biomechanics and glaucoma outcomes.

She co-leads the UdeM Haiti Glaucoma research team and collaborates with multidisciplinary groups at Maisonneuve-Rosemont Hospital. Starting autumn 2024, she will pursue a Master's in Clinical Trials at the London School of Hygiene and Tropical Medicine to advance glaucoma therapeutic research through rigorous clinical trial methodology.